Genomic Insights into Neglected Orthobunyaviruses: Molecular Characterization and Phylogenetic Analysis [PDF]
VirusesOrthobunyaviruses are a diverse group of segmented RNA viruses with significant but underexplored public and veterinary health implications. This study provides a genomic, phylogenetic, and ecological analysis of neglected Orthobunyaviruses using next ...
Safiétou Sankhe +13 more
doaj +2 more sources
Cache Valley virus: A scoping review of the global evidence. [PDF]
Zoonoses Public Health, 2019 AbstractCache Valley virus (CVV) is a mosquito‐borne RNA virus detected throughout North America, Central America and parts of South America. A limited number of human case reports have described severe illness. CVV infection has been associated with outbreaks of congenital defects in small ruminants in Canada and the United States.
Waddell L +6 more
europepmc +4 more sources
Ovine fetal immune response to Cache Valley virus infection. [PDF]
J Virol, 2013 ABSTRACTCache Valley virus (CVV)-induced malformations have been previously reproduced in ovine fetuses. To evaluate the development of the antiviral response by the early, infected fetus, before the development of immunocompetency, ovine fetuses at 35 days of gestation were inoculatedin uterowith CVV and euthanized at 7, 10, 14, 21, and 28 days ...
Rodrigues Hoffmann A +8 more
europepmc +4 more sources
Spatial-Temporal Analysis of Cache Valley Virus (Bunyaviridae: Orthobunyavirus ) Infection in Anopheline and Culicine Mosquitoes (Diptera: Culicidae) in the Northeastern United States, 1997–2012 [PDF]
Vector-Borne and Zoonotic Diseases, 2014 Philip Armstrong, Theodore Andreadis
exaly +2 more sources
Management Factors Associated with Operation-Level Prevalence of Antibodies to Cache Valley Virus and Other Bunyamwera Serogroup Viruses in Sheep in the United States [PDF]
Vector-Borne and Zoonotic Diseases, 2015 Paul Plummer +2 more
exaly +2 more sources
Fatal Cache Valley virus meningoencephalitis associated with rituximab maintenance therapy. [PDF]
Am J Hematol, 2018 Yang Y +8 more
europepmc +4 more sources
Potential entry pathways for 25 vector-borne disease agents. [PDF]
EFSA JAbstract This Scientific Report identifies the potential entry pathways for 25 selected vector‐borne diseases (VBDs) into currently free EU Member States. The diseases comprise 12 listed under the Animal Health Law (AHL) and 13 non‐listed diseases, selected using predefined eligibility criteria.
European Food Safety Authority (EFSA) +7 more
europepmc +2 more sources
Identification and mapping of potential and highly likely vectors for selected vector-borne diseases in the EU and neighbouring countries. [PDF]
EFSA JAbstract This report addresses Term of Reference 1.2 by providing a comprehensive knowledge‐mapping of arthropod vector species competent to transmit selected vector‐borne diseases (VBDs) including VBDs listed under Regulation (EU) 2016/429 and Regulation (EU) 2020/687, as well as additional non‐listed pathogens with potential epidemiological relevance.
European Food Safety Authority (EFSA) +7 more
europepmc +2 more sources
Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity. [PDF]
PLoS Neglected Tropical Diseases, 2013 BACKGROUND: Rift Valley fever (RVF) is a severe mosquito-borne disease affecting humans and domestic ruminants. Mosquito saliva contains compounds that counteract the hemostatic, inflammatory, and immune responses of the host.
Alain Le Coupanec +7 more
doaj +1 more source
Vector-borne diseases-knowledge maps. [PDF]
EFSA JAbstract This scientific report provides a structured overview of the main characteristics of 25 selected vector‐borne diseases (VBDs) of potential relevance for the EU, including 12 diseases listed under the Animal Health Law (AHL) and 13 non‐listed diseases.
European Food Safety Authority (EFSA) +7 more
europepmc +2 more sources